{"url":"https://lda.senate.gov/api/v1/filings/cdeae9c9-e00c-4d5d-b54d-13e75c0fa0e0/","filing_uuid":"cdeae9c9-e00c-4d5d-b54d-13e75c0fa0e0","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2015,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/cdeae9c9-e00c-4d5d-b54d-13e75c0fa0e0/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Alix Burns","dt_posted":"2015-07-20T23:25:02.460000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1300 CONNECTICUT AVENUE, NW","registrant_address_2":"SIXTH FLOOR","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":312190,"url":"https://lda.senate.gov/api/v1/registrants/312190/","house_registrant_id":38713,"name":"BAY BRIDGE STRATEGIES, INC.","description":"Government relations.","address_1":"750 9th Street NW","address_2":"Suite 501","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALIX BURNS","contact_telephone":"+1 202-496-2111","dt_updated":"2024-07-17T15:00:38.252249-04:00"},"client":{"id":183925,"url":"https://lda.senate.gov/api/v1/clients/183925/","client_id":176,"name":"BIOCRYST PHARMACEUTICALS, INC.","general_description":"Pharmaceutical company.","client_government_entity":false,"client_self_select":null,"state":"NC","state_display":"North Carolina","country":"US","country_display":"United States of America","ppb_state":"NC","ppb_state_display":"North Carolina","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-03-01"},"lobbying_activities":[{"general_issue_code":"DIS","general_issue_code_display":"Disaster Planning/Emergencies","description":"Issues related to pandemic preparedness and biodefense. Ebola response. Influenza preparedness. FY 16 Labor HHS Appropriations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48863,"prefix":"ms","prefix_display":"MS.","first_name":"ALEXANDRA","nickname":"ALIX","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues related to pandemic preparedness and biodefense. Ebola response. Influenza preparedness. FY 16 Labor HHS Appropriations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48863,"prefix":"ms","prefix_display":"MS.","first_name":"ALEXANDRA","nickname":"ALIX","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}